GENinCode Plc (LON:GENI – Get Free Report) fell 14.3% on Thursday . The company traded as low as GBX 2.40 and last traded at GBX 2.40. 259,079 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 833,292 shares. The stock had previously closed at GBX 2.80.
GENinCode Stock Performance
The stock has a fifty day simple moving average of GBX 2.87 and a 200-day simple moving average of GBX 2.44. The stock has a market cap of £7.34 million, a P/E ratio of -1.09 and a beta of 0.66. The company has a debt-to-equity ratio of 9.28, a quick ratio of 15.89 and a current ratio of 2.60.
GENinCode (LON:GENI – Get Free Report) last issued its quarterly earnings results on Tuesday, September 30th. The company reported GBX (1.19) EPS for the quarter. GENinCode had a negative net margin of 228.70% and a negative return on equity of 289.74%. On average, equities analysts expect that GENinCode Plc will post -7.1299999 earnings per share for the current year.
About GENinCode
GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.
See Also
- Five stocks we like better than GENinCode
- 3 Warren Buffett Stocks to Buy Now
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- Why Are Stock Sectors Important to Successful Investing?
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
